| GTO ID | GTC2184 |
| Trial ID | NCT04089215 |
| Disease | Diffuse Large B-Cell Lymphoma | Follicular Lymphoma | Non-Hodgkin's Lymphoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | 1RG CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Trial of Anti-GD2 T-cells (1RG-CART) |
| Year | 2019 |
| Country | United Kingdom |
| Company sponsor | Shanghai Ming Ju Biotechnology Co., Ltd. |
| Other ID(s) | JWCAR029-002 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||